Arcese W - Search Results

1

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.

Cerva C, Colagrossi L, Maffongelli G, Salpini R, Di Carlo D, Malagnino V, Battisti A, Ricciardi A, Pollicita M, Bianchi A, Picardi A, Cudillo L, Cerretti R, De Angelis G, Cantonetti M, Andreoni M, Perno CF, Arcese W, Svicher V, Sarmati L. Cerva C, et al. Among authors: arcese w. Clin Microbiol Infect. 2016 Nov;22(11):946.e1-946.e8. doi: 10.1016/j.cmi.2016.07.021. Epub 2016 Jul 27. Clin Microbiol Infect. 2016. PMID: 27475741 Free article.

2

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W. Mengarelli A, et al. Among authors: arcese w. Haematologica. 2002 Jan;87(1):52-8. Haematologica. 2002. PMID: 11801465

3

Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature.

Del Giudice I, Iori AP, Mengarelli A, Testi AM, Romano A, Cerretti R, Macrì F, Iacobini M, Arcese W. Del Giudice I, et al. Among authors: arcese w. Ann Hematol. 2003 Mar;82(3):189-92. doi: 10.1007/s00277-002-0590-0. Epub 2003 Feb 12. Ann Hematol. 2003. PMID: 12634956 Review.

4

One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.

Mengarelli A, Iori AP, Romano A, Cerretti R, Cerilli L, De Propris MS, Fenu S, Moleti ML, De Felice L, Girelli G, Arcese W. Mengarelli A, et al. Among authors: arcese w. Haematologica. 2003 Mar;88(3):315-23. Haematologica. 2003. PMID: 12651271

5

Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease.

Lo-Coco F, Romano A, Mengarelli A, Diverio D, Iori AP, Moleti ML, De Santis S, Cerretti R, Mandelli F, Arcese W. Lo-Coco F, et al. Among authors: arcese w. Leukemia. 2003 Oct;17(10):1930-3. doi: 10.1038/sj.leu.2403078. Leukemia. 2003. PMID: 14513040

6

Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation.

Iori AP, Cerretti R, De Felice L, Screnci M, Mengarelli A, Romano A, Caniglia M, Cerilli L, Gentile G, Moleti ML, Giona F, Agostini F, Pasqua I, Perrone MP, Pinto MR, Grapulin L, Testi AM, Martino P, De Rossi G, Mandelli F, Arcese W. Iori AP, et al. Among authors: arcese w. Bone Marrow Transplant. 2004 Jun;33(11):1097-105. doi: 10.1038/sj.bmt.1704500. Bone Marrow Transplant. 2004. PMID: 15094744

7

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

Maurillo L, Buccisano F, Del Principe MI, Del Poeta G, Spagnoli A, Panetta P, Ammatuna E, Neri B, Ottaviani L, Sarlo C, Venditti D, Quaresima M, Cerretti R, Rizzo M, de Fabritiis P, Lo Coco F, Arcese W, Amadori S, Venditti A. Maurillo L, et al. Among authors: arcese w. J Clin Oncol. 2008 Oct 20;26(30):4944-51. doi: 10.1200/JCO.2007.15.9814. Epub 2008 Jul 7. J Clin Oncol. 2008. PMID: 18606980 Free article.

8

Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion.

Cudillo L, Cerretti R, Baliva G, De Angelis G, Postorino M, Picardi A, Mirabile M, Lanti A, Cantonetti M, Arcese W. Cudillo L, et al. Among authors: arcese w. Bone Marrow Transplant. 2009 Feb;43(4):347-8. doi: 10.1038/bmt.2008.333. Epub 2008 Oct 13. Bone Marrow Transplant. 2009. PMID: 18850017 No abstract available.

9

Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation.

Tirindelli MC, Flammia G, Sergi F, Cerretti R, Cudillo L, Picardi A, Postorino M, Annibali O, Greco R, Avvisati G, Arcese W. Tirindelli MC, et al. Among authors: arcese w. Transfusion. 2009 Jan;49(1):170-5. doi: 10.1111/j.1537-2995.2008.01934.x. Epub 2008 Oct 2. Transfusion. 2009. PMID: 18954405

10

Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report.

Vischini G, Cudillo L, Ferrannini M, Di Daniele N, Cerretti R, Arcese W. Vischini G, et al. Among authors: arcese w. J Nephrol. 2009 Jan-Feb;22(1):160-3. J Nephrol. 2009. PMID: 19229832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page